View in EDS PDF Full Text

Programmable RNA editing with endogenous ADAR enzymes - a feasible option for the treatment of inherited retinal disease?

Saved in:
Bibliographic Details
Title: Programmable RNA editing with endogenous ADAR enzymes - a feasible option for the treatment of inherited retinal disease?
Authors: Bellingrath JS; Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom., McClements ME; Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom., Fischer MD; Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.; Oxford Eye Hospital, Oxford University Hospitals NHS Trust, Oxford, United Kingdom., MacLaren RE; Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.; Oxford Eye Hospital, Oxford University Hospitals NHS Trust, Oxford, United Kingdom.
Source: Frontiers in molecular neuroscience [Front Mol Neurosci] 2023 May 24; Vol. 16, pp. 1092913. Date of Electronic Publication: 2023 May 24 (Print Publication: 2023).
Publication Type: Journal Article; Review
Journal Info: Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101477914 Publication Model: eCollection Cited Medium: Print ISSN: 1662-5099 (Print) Linking ISSN: 16625099 NLM ISO Abbreviation: Front Mol Neurosci Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37293541
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Programmable RNA editing with endogenous ADAR enzymes - a feasible option for the treatment of inherited retinal disease?
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bellingrath+JS%22">Bellingrath JS</searchLink>; Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22McClements+ME%22">McClements ME</searchLink>; Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Fischer+MD%22">Fischer MD</searchLink>; Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.; Oxford Eye Hospital, Oxford University Hospitals NHS Trust, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22MacLaren+RE%22">MacLaren RE</searchLink>; Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.; Oxford Eye Hospital, Oxford University Hospitals NHS Trust, Oxford, United Kingdom.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101477914%22">Frontiers in molecular neuroscience</searchLink> [Front Mol Neurosci] 2023 May 24; Vol. 16, pp. 1092913. <i>Date of Electronic Publication: </i>2023 May 24 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation%22">Frontiers Research Foundation </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101477914 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1662-5099 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216625099%22">16625099 </searchLink><i>NLM ISO Abbreviation: </i>Front Mol Neurosci <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37293541
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fnmol.2023.1092913
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1092913
    Titles:
      – TitleFull: Programmable RNA editing with endogenous ADAR enzymes - a feasible option for the treatment of inherited retinal disease?
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bellingrath JS
      – PersonEntity:
          Name:
            NameFull: McClements ME
      – PersonEntity:
          Name:
            NameFull: Fischer MD
      – PersonEntity:
          Name:
            NameFull: MacLaren RE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 24
              M: 05
              Text: 2023 May 24
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 1662-5099
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in molecular neuroscience
              Type: main
ResultId 1